Yiğit GÜNEŞ, Ceren ANLAŞ, Banu DOKUZEYLÜL

Pharmacological and clinical approach to plant based complementary health products in lower urinary system diseases in cats and dogs

Medicinal plants, which are widely used in the treatment of many diseases in folk medicine, are alternative treatment approaches that allow to overcome the limitations of modern treatments such as high treatment costs and difficulty in accessing health services. In addition to their traditional uses, the World Health Organization (WHO) also recommends the use of medicinal plants as alternative applications, especially in countries where have limited access to modern medical facilities. Limitations on the methods used in the treatment of lower urinary tract diseases such as urinary tract infection and urolithiasis in both human and veterinary practice (high treatment cost, low tolerability, development of antibacterial resistance, etc.) have brought the use of natural products of herbal origin within the scope of supportive/complementary treatment approaches. Although the mechanism of action of medicinal plants in the treatment of lower urinary tract diseases is not clearly known, studies have shown that they increase the glomerular filtration rate; and they can be complementary alternatives to conventional treatment due to their anti-lithogenic, antibacterial, antioxidant and anti-inflammatory activities. Patients that referred to with one or more of the symptoms of urinary system diseases such as polyuria, pollakiuria, dysuria, stranguria, anuria, hematuria, urinary incontinence constitute the case group of one of the first three systemic diseases most frequently brought to the clinic. Failure to intervene in the diseases shaped in the lower urinary system in a timely manner causes negative consequences such as the disease becoming chronic, the progression of the disease to the upper urinary system in progressive cases, and a decrease in the quality of life. Complementary products used in addition to medical treatment are sometimes used for prophylactic purposes. In this context, many supplements have been prescribed for different diseases in small animal practice in recent years. In this review, it is aimed to convey current developments about medicinal plants, which are used effectively within the scope of supportive treatment practices in lower urinary system diseases of cats and dogs, to veterinary clinical practice.

Keywords:

Keywords: Lower urinary tract diseases, complementary therapy medicinal plants, cat, dog.,

PDF

___

• Al-Ali, M., Wahbi, S., Twaij, H., & Al-Badr, A. (2003). Tribulus terrestris: preliminary study of its diuretic and contractile effects and comparison with Zea mays. Journal of Ethnopharmacology, 85(2-3), 257-260.
• Altınok Yipel, F., & Yipel, M. (2014). Etnoveteriner hekimlik (EVH). TVHB Dergisi, 14(1-2), 79-82.
• Bag, A., Bhattacharyya, S. K., & Chattopadhyay, R. R. (2008). Medicinal plants and urinary tract infections: an update. Pharmacognosy Reviews, 2, 277–84.
• Beachey, E. H. (1981). Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface. Journal of Infectious Diseases, 143, 325-345.
• Beaux, D., Fleurentin, J., & Mortier, F. (1999). Effect of extracts of Orthosiphon stamineus benth, Hieracium pilosella L., Sambucus nigra L. and Arctostaphylos uva‐ursi (L.) spreng. in rats. Phytotherapy Research, 13(3), 222-225.
• Bernal, J., Mendiola, J. A., Ibáñez, E., & Cifuentes, A. (2011). Advanced analysis of nutraceuticals. Journal of Pharmaceutical and Biomedical Analysis, 55(4), 758-774.
• Blumenthal, M., Goldberg, A., & Brinckmann, J. (2000) eds. Herbal Medicine. Expanded Commission E Monographs. Austin, Texas, US: American Botanical Council.
• Bol, S., Caspers, J., Buckingham, L., Anderson-Shelton, G. D., Ridgway, C., Buffington, C. A., & Bunnik, E. M. (2017). Responsiveness of cats (Felidae) to silver vine (Actinidia polygama), Tatarian honeysuckle (Lonicera tatarica), valerian (Valeriana officinalis) and catnip (Nepeta cataria). BMC Veterinary Research, 13(1), 1-16.
• Bradley, P. R. (1992). British herbal compendium. Volume 1. A handbook of scientific information on widely used plant drugs. Companion to Volume 1 of the British Herbal Pharmacopoeia. British Herbal Medicine Association.
• British Herbal Medicine Association. (2003). A Guide to Traditional Herbal Medicines. Bournemouth, UK: British Herbal Medicine Association Publishing.
• British Herbal Pharmacopoeia. (1983). UK: Keighley, British Herbal Medicine Association.
• Daniels, M., Bartges, J. W., Raditic, D. M., Kirk, C. A., Callens, A., Marsden, S., & Galyon, G. (2011). Evaluation of 3 herbal compounds used for management of lower urinary tract disease in cats. In Journal Of Veterinary Internal Medicine (pp. 721-722). Malden, MA: US: Wiley-Blackwell.
• Das, P. (1974). Antiinflammatory and antiarthritc activity of varuna. Journal of Research Indian Medicine, 9:49.
• De Smet, P. A., Keller, K., Hänsel, R., & Chandler, R. F. (Eds.). (1992). Adverse effects of herbal drugs (pp. 1-13). Berlin/Heidelberg, Germany: Springer.
• Deshpande, P., Sahu M., & Kumar, P. (1982). Crataeva nurvala hook and forst (varun): the ayurvedic drug of choice in urinary disorders. Indian Journal of Medicinal Research, 76, 46-53.
• Didry, N. & Pinkas, M. A propos du Buchu. (1982). Plantes Méd et Phyothér, 16, 249-252.
• Elhajili, M., Baddouri, K, Elkabbaj, S., Meiouat, F., & Settaf, A. (2001). Diuretic activity of the infusion of flowers from Lavendula officinalis. Reproduction, Nutrition, Development, 41, 393-399.
• Ernst & Young (2010) Beyond Borders Global Biotechnology Report, New York.
• Grases, F., Ramis, M., Costa-Bauza, A., & March, J. G. (1995). Effect of Herniaria hirsuta and Agropyron repens on calcium oxalate urolithiasis risk in rats. Journal of Ethnopharmacology, 45(3), 211-214.
• Grieve, M. (1931). A Modern Herbal. New York: Dover Publications.
• Habtemariam, S. (2001). Antiinflammatory activity of the antirheumatic herbal drug, gravel root (Eupatorium purpureum): further biological activities and constituents. Phytotherapy Research, 15(8), 687-690.
• Hook, I., McGee, A., & Henman, M. (1993). Evaluation of dandelion for diuretic activity and variation in potassium content. International Journal of Pharmacognosy, 31(1), 29-34.
• Howell, A. B., Vorsa, N., Marderosian, A. D., & Foo, L. Y. (1998). Inhibition of the adherence of P-fimbriated Escherichia coli to uroepithelial-cell surfaces by proanthocyanidin extracts from cranberries. New England Journal of Medicine, 339(15), 1085-1086.
• Howell, A. B., Griffin, D. W., & Whalen, M. O. (2010). Inhibition of p-fimbriated Escherichia coli adhesion in an innovational ex-vivo model in dogs receiving a bioactive cranberry tablet (Crananidin). In Journal Of Veterinary Internal Medicine (pp. 678-678). Malden, MA, US: Wiley-Blackwell.
• Karaoğlan EES & Özgen U. Bazı origanum türleri üzerinde farmakognozik çalışmalar. PhD thesis, University of Ataturk, Erzurum, Turkey.
• Kendir, G., & Güvenç, A. (2010). Etnobotanik ve Türkiye’de yapılmış etnobotanik çalışmalara genel bir bakış. Hacettepe University Journal of the Faculty of Pharmacy, (1), 49-80.
• Kidd, R. (2000). Dr. Kidd's Guide to Herbal Cat Care. Pownal, Vermont, US: Storey Publishing.
• Kingwatanakul, P., & Alon, U. S. (1996). Cranberries and urinary tract infection. Children’s Hospital Quarterly, 8:69-72.
• Kreydiyyeh, S. I. (2002). Diuretic effect and mechanism of action of parsley. Journal of Ethnopharmacology, 79(3), 353-357.
• Leung, A.Y. (1980). Encyclopedia of common natural ingredients used in food, drugs and cosmetics. New York-Chichester, US: Wiley.
• Lis‐Balchin, M., Hart, S., & Simpson, E. (2001). Buchu (Agathosma betulina and A. crenulata, rutaceae) essential oils: Their pharmacological action on guinea‐pig ileum and antimicrobial activity on microorganisms. Journal of Pharmacy and Pharmacology, 53(4), 579-582.
• Litster, A., Thompson, M., Moss, S., & Trott, D. (2011). Feline bacterial urinary tract infections: An update on an evolving clinical problem. The Veterinary Journal, 187(1), 18-22.
• Matsuda, H., Nakamura, S., Tanaka, T., & Kubo, M. (1992). Pharmacological studies on leaf of Arctostaphylos uva-ursi (L.) Spreng. V. Effect of water extract from Arctostaphylos uva-ursi (L.) Spreng.(bearberry leaf) on the antiallergic and antiinflammatory activities of dexamethasone ointment. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan, 112(9), 673-677.
• McHarg, T., Rodgers, A., & Charlton, K. (2003). Influence of cranberry juice on the urinary risk factors for calcium oxalate kidney stone formation. BJU International, 92(7), 765-768.
• Nishihata, M., Kohjimoto, Y., & Hara, I. (2013). Effect of Kampo extracts on urinary stone formation: An experimental investigation. International Journal of Urology, 20(10), 1032-1036.
• Peixoto, I. T. A., Furlanetti, V. F., Anibal, P. C., Duarte, M. C. T., & Höfling, J. F. (2009). Potential pharmacological and toxicological basis of the essential oil from Mentha spp. Revista de Ciências Farmacêuticas Básica e Aplicada, 30(3), 235-9.
• Prabhakar, Y. S., & Kumar, D. S. (1997). Crataeva nurvala: An ayurvedic remedy for urological disorders. British Journal of Phytotherapy, 4, 103-109.
• Râcz–Kotilla, E., Racz, G., & Solomon, A. (1974). The action of Taraxacum officinale extracts on the body weight and diuresis of laboratory animals. Planta Medica, 26(07), 212-217.
• Raditic, D. M. (2015). Complementary and integrative therapies for lower urinary tract diseases. Veterinary Clinics: Small Animal Practice, 45(4), 857-878.
• Reid, G., & Sobel, J. D. (1987). Bacterial adherence in the pathogenesis of urinary tract infection: a review. Reviews of Infectious Diseases, 9(3), 470-487.
• Schmidt, D. R., & Sobota, A. E. (1988). An examination of the anti-adherence activity of cranberry juice on urinary and nonurinary bacterial isolates. Microbios, 55(224-225), 173-181.
• Terris, M. K., Issa, M. M., & Tacker, J. R. (2001). Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology, 57(1), 26-29.
• Thompson, M. F., Litster, A. L., Platell, J. L., & Trott, D. J. (2011). Canine bacterial urinary tract infections: new developments in old pathogens. The Veterinary Journal, 190(1), 22-27.
• Tisserand, R., & Balacs, T. (1995). Essential Oil Safety. Edinburgh, UK: Churchill Livingstone.
• Tita, B., Bello, U., Faccendini, P., Bartolini, R., & Bolle, P. (1993). Taraxacum officinale W.: pharmacological effect of ethanol extract. Pharmacological Research, 27, 23-24.
• Tyler, V. E. (1993). The Honest Herbal. 3rd ed. Philadelphia, US: Strickley.
• Wen, J. J., & Johnston, K. (2012). Treatment of urolithiasis in 33 dogs and 13 cats with a novel chinese herbal medicine. American Journal of Traditional Chinese Veterinary Medicine, 7(2), 39-45.
• Wheatley, D. (2005). Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability. Journal of Psychopharmacology, 19(4), 414-421.
• Willard, T. 1991. The Wild Rose Scientific Herbal. Calgary, Canada: Wild Rose College of Natural Healing.
• Wren, R.C. (1988). Potter’s new cyclopedia of botanical drugs and preparations. London, UK: Potter & Clarke.
• Wulff-Tilford, M., & Tilford, G. L. (1999). All you ever wanted to know about herbs for pets. US: BowTie Press.
• Wynn, S. G., & Fougère, B. J., (2007). Veterinary herbal medicine: A systems-based approach. In S. G. Wynn, B. J. Fougère (Ed.) Veterinary herbal medicine. (pp. 291-409). St Louis, US: Elsevier Health Sciences.
• Wynn, S. G., & Marsden, S., (2003). Manual of Natural Veterinary Medicine: Science and tradition. St Louis, US: Mosby Inc.